Page 24 | Certara

Publication

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…

CertaraMarch 4, 2025

Blog

Machine Learning for PK/PD Modeling in Drug Development

Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…

CertaraMarch 4, 2025

On-Demand Webinar

CDISC data standards – Beyond value [Korean Webinar]

March 13, 2025 - 3:00 pm Korea

CertaraMarch 3, 2025

Webinar

Phoenix NLME & Pirana: Powerful popPK Modeling Software for Streamlined Pharmacometric Workflows

CertaraMarch 3, 2025

Video

Pinnacle 21 – Data standardization and validation for faster analysis and submission

CertaraMarch 3, 2025

Poster

Comparison Across Anti-PD-1 Antibodies – Insights From QSP-Based Meta-Analysis

Regulatory-ready systems modeling software to optimize drug developmentDiscover how Certara’s QSP Software can accelerate your…

CertaraMarch 2, 2025

Blog

How the US FDA MIDD paired pilot program helps sponsors

February 28, 2025 For the past couple of decades, leading American institutions, pharmaceutical and biotechnology…

CertaraFebruary 28, 2025

White Paper

Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and Europe

Lorem ipsum dolor sit amet consectetur. At venenatis urna sapien ut lorem enim. Morbi lectus…

CertaraFebruary 28, 2025

Webinar

Phoenix WinNonlin & PK Submit: Industry-Standard Software for Smarter PK/PD Workflows

CertaraFebruary 28, 2025

On-Demand Webinar

PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]

Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…

CertaraFebruary 27, 2025

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy